BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 24964962)

  • 1. MicroRNAs in cancer stem cells: current status and future directions.
    Chhabra R; Saini N
    Tumour Biol; 2014 Sep; 35(9):8395-405. PubMed ID: 24964962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.
    Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B
    J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of microRNAs in cancer and cancer stem cells.
    Hao J; Zhao S; Zhang Y; Zhao Z; Ye R; Wen J; Li J
    J Cell Biochem; 2014 Apr; 115(4):605-10. PubMed ID: 24166873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs and cancer stem cells: the sword and the shield.
    Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
    Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.
    Nalls D; Tang SN; Rodova M; Srivastava RK; Shankar S
    PLoS One; 2011; 6(8):e24099. PubMed ID: 21909380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
    Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
    Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs and cancer stem cells: therapeutic approaches and future perspectives.
    Leal JA; Lleonart ME
    Cancer Lett; 2013 Sep; 338(1):174-83. PubMed ID: 22554710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells.
    Yu Z; Pestell TG; Lisanti MP; Pestell RG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating miRNA by natural agents as a new strategy for cancer treatment.
    Sethi S; Li Y; Sarkar FH
    Curr Drug Targets; 2013 Sep; 14(10):1167-74. PubMed ID: 23834152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic approaches targeting cancer stem cells.
    Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
    J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [MicroRNAs Regulation of Cancer Stem Cells].
    Zhang JP; Jia YS; Tong ZS
    Sheng Li Ke Xue Jin Zhan; 2015 Feb; 46(1):17-22. PubMed ID: 26103721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness.
    Ma Y; Shen N; Wicha MS; Luo M
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel reporter construct for screening small molecule inhibitors that specifically target self-renewing cancer cells.
    Shanmugam G; Mohan A; Kumari K; Louis JM; Soumya Krishnan U; Balagopal PG; George NA; Sebastian P; Maliekal TT
    Exp Cell Res; 2019 Oct; 383(2):111551. PubMed ID: 31401066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells?
    Gunaratne PH
    Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance.
    Tuysuz EC; Gulluoglu S; Yaltirik CK; Ozbey U; Kuskucu A; Çoban EA; Sahin F; Türe U; Bayrak OF
    Exp Cell Res; 2019 Jul; 380(1):9-19. PubMed ID: 30951707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expression.
    Su YK; Shih PH; Lee WH; Bamodu OA; Wu ATH; Huang CC; Tzeng YM; Hsiao M; Yeh CT; Lin CM
    J Ethnopharmacol; 2017 Jul; 207():47-56. PubMed ID: 28602756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.